The reflection of 2023 is an excellent segue into looking at what 2024 will bring – and in a word it will be ‘InFusion’. InFusion is our new membership designed to support Regulatory Affairs Departments and professionals within the UK. InFusion has been on the cards for several years and our developers are working hard to bring this bespoke membership and e-learning platform to life.
There will be two levels of access:
InFusion Graduate
Our high value, low cost membership for graduates and budding Regulatory professionals who are committed to laying down the foundations to a successful career. Containing a suite of introductory level training courses, practical experience, career advice and interview techniques. We will walk our members through creating a professional biography which we will share with all of our Professional members.
Access will be heavily subsidised representing our commitment to developing the next generation of regulatory affairs professionals. We will also be giving away 10 free memberships (upon successful application) so keep watching for an announcement!
InFusion Professional
This will host our more advanced training courses and resources aimed at UK Regulatory Affairs Departments and professionals. Our forum will be the place to be for conversations with other UK professionals to ask questions and share knowledge and experience. You will also receive regular UK regulatory intelligence updates, including suggested actions.
There will be an ‘optional extra’ to engage further with the team at Fusion Pharma and have monthly one to one coaching sessions and/or department or product strategy calls.
Our professional members will have the advantage of being able to view the professional biography of our graduate members in order to have access to committed individuals taking their development seriously and who are ready for the next career move.
The whole team at Fusion Pharma are feeling very excited about this new offering.
There will be more exciting updates released early 2024 so please follow us on LinkedIn for the latest communication on this.
